Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

J Natl Cancer Inst. 1999 Sep 15;91(18):1587-90. doi: 10.1093/jnci/91.18.1587.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Asian People / genetics
  • Calcium Channel Blockers / metabolism
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 Enzyme System / biosynthesis
  • Cytochrome P-450 Enzyme System / genetics*
  • Enzyme Induction
  • Genotype
  • Humans
  • Male
  • Microsomes, Liver / enzymology
  • Mixed Function Oxygenases / biosynthesis
  • Mixed Function Oxygenases / genetics*
  • Nifedipine / metabolism
  • Oxidation-Reduction
  • Polymorphism, Genetic
  • Polymorphism, Restriction Fragment Length
  • Prostatic Neoplasms / enzymology*
  • Prostatic Neoplasms / ethnology
  • Prostatic Neoplasms / genetics*
  • White People / genetics

Substances

  • Calcium Channel Blockers
  • Cytochrome P-450 Enzyme System
  • Mixed Function Oxygenases
  • CYP3A protein, human
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human
  • Nifedipine